About Conference
Asian Symposium on Advancement in Hematology and Oncology promotes scientific exchange, clinical excellence, and innovations in cancer care.
Highlights
Expert presentations, breakthrough research, hematologic malignancy updates, oncology advancements, case discussions, & collaborative learning opportunities. This promotes scientific exchange, clinical excellence, & innovations in cancer care.
Recommended News For You
Recommended Articles For You
Featured News
Featured Articles
Featured Events
Featured KOL Videos
1.
Using AI, one can find cancer risk factors.
2.
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll
3.
FDA Approves Monthly Dosing of Rybrevant Faspro for NSCLC
4.
Does pollution cause cancer?
5.
Clinical Evidence Shows Venetoclax Combo Is Safe and Effective in AML Patients 80 Years of Age and Up.
1.
Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges
2.
CAR-T Cell Therapy for Diffuse Large B-Cell Lymphoma: A Comprehensive Review
3.
Cancer Vaccines in Solid Tumors: Current Landscape, Mechanisms, and Clinical Implications
4.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
5.
Unveiling the Hidden Benefits of Lymphedema Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
2.
Lorlatinib in the Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
3.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
5.
Evolving Space of First-Line Treatment for Urothelial Carcinoma- Case Discussion
Recommended News For You
1.
Early Tislelizumab May Boost PFS in Esophageal Cancer
2.
For the treatment of paroxysmal nocturnal hemoglobinuria, the FDA has approved an oral factor B inhibitor.
3.
'Ticking Time Bomb'; Jimmy Carter's Lasting Impact on Cancer; Breast Cancer-CVD Link
4.
Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group
5.
Pirtobrutinib May Be Beneficial in Follicular Lymphoma with Severe Pretreatment.
Conferences That Might Interest You
Recommended Articles For You
1.
Ticagrelor Monotherapy vs. Ticagrelor + Aspirin in ACS Post-PCI: ULTIMATE-DAPT Trial
2.
Everything You Need To Know About Trichelemmal Cysts: Symptoms, Causes, Diagnosis And Treatment
3.
The Importance of Early Detection: How Genetics Play a Role in Leucocythemia Diagnosis
4.
A Closer Look at MCV Modules: Features, Functions, and Benefits
5.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
Boost Your Knowledge With These Quizzes
1.
Quiz on Systemic Lupus Erythematosus
2.
Quiz on Low-Field MRI's Diagnostic Potential for Hematoma
3.
Quiz on Unlocking Fertility: Reproductive Endocrinology in Male Infertility
4.
Quiz on Platelet Mysteries: Decoding Inherited Disorders and Their Clinical Impact
5.
Quiz on Unraveling the Mystery of Gastrinoma and Zollinger-Ellison Syndrome
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Welcome to Hidoc Dr.
Join to enhance your clinical skills and gain specialized in-depth medical knowledge